STAT Plus: Agios CEO forecasts ‘line of sight’ to more approved drugs and profits
RUBY WALLAU FOR STAT
The company unveiled a strategic plan — including a mandate to trim losses and become cash-flow positive — ahead of the J.P. Morgan Healthcare Conference.
.png)
No hay comentarios:
Publicar un comentario